A secondary packaging package

CN224618341UActive Publication Date: 2026-08-11HANGZHOU QIANTANG LONGYUE BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2025-10-11
Publication Date
2026-08-11

AI Technical Summary

Technical Problem

[0004]本实用新型的目的在于提供一种二次封装包装盒,解决了药厂需要分拣组合统一包装而费时费力的问题,利用同一包装盒,器械厂和药厂分次装入各自生产的部件,大大提高了效率,降低了成本

Benefits of technology

1、本实用新型,通过提供一种预先集成并固定了所有医疗器械的包装半成品,将最繁琐的器械分拣、组装环节前置至器械供应商端完成,药厂仅需执行二次密封这一步骤,有效解决了药厂需要进行额外组装作业,增加人工操作环节、工时消耗和管理成本的问题,极大简化了药厂的生产流程,显著降低了人力和管理成本,提高了整体生产效率。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224618341U_ABST
    Figure CN224618341U_ABST
Patent Text Reader

Abstract

This utility model relates to the field of plastic packaging technology and discloses a secondary-sealing packaging box, comprising: a box body, the box body having a receiving cavity for accommodating syringes, filter needles, injection needles, and vials; the opening of the box body has a primary sealing area and a secondary sealing area, the primary sealing area corresponding to the area within the receiving cavity for accommodating syringes, filter needles, and injection needles, and the secondary sealing area corresponding to the area within the receiving cavity for accommodating vials; the primary sealing area and the secondary sealing area are independent of each other, allowing the sealing film to first cover and seal the primary sealing area, while the secondary sealing area remains open and is resealed by the sealing film after the vials are inserted. This utility model forwards the most cumbersome instrument sorting and assembly process to the instrument supplier, requiring the pharmaceutical factory to only perform the secondary sealing step, effectively solving the problem of the need for additional assembly work by pharmaceutical factories.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This utility model relates to the field of plastic packaging technology, specifically a secondary packaging box. Background Technology

[0002] In the field of drug therapy, core drugs are often stored in vials as lyophilized powder. When used, a syringe with a filter needle is used to inject the diluent into the vial, then the mixture is withdrawn, and finally, an injection needle is used to complete the injection. This process requires a syringe, filter needle, injection needle, and vials containing the lyophilized drug powder. Currently, the industry standard is for pharmaceutical companies to handle the standardized packaging of these components. Medical device manufacturers provide syringes, various needles, and other device components to pharmaceutical companies in individual sterile packages. After filling the drug vials, the pharmaceutical companies need to manually or semi-automatically collect, assemble, and pack the drug vials and multiple device components into the final sales packaging box, and then seal it.

[0003] The applicant found that in implementing the existing solution, pharmaceutical companies need to manage the inventory and supply chain of drugs and various medical devices separately, and additional assembly operations are required. This not only increases the number of manual operations, labor hours and management costs on the production line, reducing overall production efficiency, but also increases the risk of product contamination or incorrect packaging due to the need for multiple manual sorting and assembly operations. There is still room for improvement in aseptic assurance. Based on this, this utility model designs a secondary packaging box to solve the above problems. Utility Model Content

[0004] The purpose of this invention is to provide a secondary packaging box that solves the problem of pharmaceutical factories having to sort and combine components for unified packaging, which is time-consuming and labor-intensive. By using the same packaging box, medical device factories and pharmaceutical factories can pack their respective manufactured parts in batches, which greatly improves efficiency and reduces costs.

[0005] To solve the above-mentioned technical problems, this utility model provides the following technical solution: A secondary packaging box, comprising: The box body has a receiving cavity for accommodating syringes, filter needles, injection needles and vials; The box body has a primary sealing area and a secondary sealing area at its opening. The primary sealing area corresponds to the area in the accommodating cavity used to accommodate syringes, filter needles, and injection needles, and the secondary sealing area corresponds to the area in the accommodating cavity used to accommodate vials. The primary sealing area and the secondary sealing area are independent of each other, so that the sealing film can first cover and seal the primary sealing area, while the secondary sealing area remains open and is resealed by the sealing film after being filled into the vial.

[0006] Preferably, the top of the box is provided with a sealing mark for aligning the boundaries of the primary sealing area and the secondary sealing area when positioning the sealing film. The box is also provided with a positioning hole that penetrates its top and bottom for sealing and positioning.

[0007] Preferably, the accommodating cavity is formed by an integrally molded rigid blister tray, which is fixed inside the box body. The rigid blister tray is provided with a nesting groove that is adapted to the shape of the syringe, filter needle, injection needle and vial.

[0008] Preferably, the nesting slots have a two-row structure, with one row for holding the syringe and the other row for holding the filter needle, injection needle, and vial. Since the area occupied by the filter needle, injection needle, and vial combined is roughly the same as that of the syringe, this layout minimizes the overall volume of the packaging box, reducing costs and facilitating transportation.

[0009] Preferably, the nesting slots for holding filter needles and injection needles are interconnected; the nesting slots for holding vials and injection needles are also interconnected. The interconnection provides deformation space for the nesting slots, facilitating the insertion of instruments.

[0010] Preferably, the nesting groove for holding the filter needle or injection needle consists of a needle groove and a needle body groove of different widths. Because the needle is larger than the needle body, this assembly structure prevents axial movement after the needle is inserted, allowing for better fixation.

[0011] Preferably, the rigid blister insert is provided with a snap-fit ​​structure for detachably securing the syringe, filter needle and injection needle in their corresponding nesting slots.

[0012] Preferably, the snap-fit ​​structure is formed by the inward protrusion of the sidewall of the nested groove.

[0013] Preferably, one corner of the box has a recessed stepped surface. After plastic sealing, this forms an easy-tear corner, making it convenient to start tearing the plastic film at this point.

[0014] Compared with the prior art, the beneficial effects achieved by this utility model are: 1. This utility model provides a pre-integrated and fixed semi-finished package of all medical devices, which moves the most cumbersome device sorting and assembly process to the device supplier. The pharmaceutical factory only needs to perform the secondary sealing step, which effectively solves the problem of pharmaceutical factories needing to perform additional assembly work, increasing manual operation, labor time consumption and management costs. It greatly simplifies the production process of pharmaceutical factories, significantly reduces labor and management costs, and improves overall production efficiency.

[0015] 2. In this utility model, the medical device is sealed in the primary sealing area when it leaves the factory, forming an independent and reliable barrier. During the process of filling the medicine, the pharmaceutical factory does not need to touch or disturb the sealed device, which fundamentally avoids the risk of product contamination or incorrect packaging caused by multiple manual sorting and assembly operations. After the secondary sealing is completed and the overall seal is completed, the sterility and safety of the end product are further ensured. Attached Figure Description

[0016] Figure 1 This is a schematic diagram of the overall structure of this utility model; Figure 2 This is a side view of the structure of this utility model; Figure 3 This is a schematic diagram of the primary and secondary sealing areas of this utility model; Figure 4 This utility model Figure 3 Enlarged view of point A.

[0017] The components include: 1. Box body; 2. Syringe; 3. Filter needle; 4. Injection needle; 5. Vial; 6. Primary sealing area; 7. Secondary sealing area; 8. Sealing mark; 9. Positioning hole; 10. Rigid blister inner tray; 11. Nesting groove; 12. Snap-on structure; 13. Needle groove; 14. Needle body groove; 15. Stepped surface. Detailed Implementation

[0018] The technical solutions of the present utility model will be clearly and completely described below with reference to the accompanying drawings of the embodiments. Obviously, the described embodiments are only some embodiments of the present utility model, and not all embodiments. Based on the embodiments of the present utility model, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the protection scope of the present utility model.

[0019] Please refer to Figures 1-4 A secondary packaging box, comprising: Box 1, with a cavity inside for accommodating syringe 2, filter needle 3, injection needle 4 and vial 5; The opening of the box body 1 is provided with a primary sealing area 6 and a secondary sealing area 7. The primary sealing area 6 corresponds to the area in the accommodating cavity used to accommodate the syringe 2, the filter needle 3, and the injection needle 4. The secondary sealing area 7 corresponds to the area in the accommodating cavity used to accommodate the vial 5. The primary sealing area 6 and the secondary sealing area 7 are independent of each other, so that the sealing film can first cover and seal the primary sealing area 6, while the secondary sealing area 7 remains open and is resealed by the sealing film after the vial 5 is filled.

[0020] The top of the box body 1 is provided with a plastic sealing mark 8, which is used to align the boundaries of the primary plastic sealing area 6 and the secondary plastic sealing area 7 when positioning the plastic sealing film. The box body 1 is also provided with a positioning hole 9 that runs through its top and bottom for sealing and positioning.

[0021] In this embodiment of the invention, the primary sealing area 6 is sealed. This area corresponds to all the instrument components inside the box, sealing the syringe 2, filter needle 3, and injection needle 4 together for easy transport. At this time, the syringes 2 in the lower row are completely sealed in a sterile environment. Although the upper row has space reserved for installing vials 5 due to the need for secondary packaging, the filter needles 3 and injection needles 4 are already within a sterile barrier because they are each sealed in protective sleeves. Thus, a semi-finished "integrated instrument package" with reserved space for vials 5 is completed, and the instrument supplier can supply this semi-finished product to the pharmaceutical manufacturer. The pharmaceutical manufacturer inserts the vials 5 produced by the manufacturer into the corresponding nesting slots 11 reserved on the rigid blister tray 10, and uses the sealing equipment again, using the positioning holes 9 and sealing marks 8 for positioning, to perform heat sealing on the secondary sealing area 7. This sealing completely seals the pharmaceutical vials 5 and the previously sealed instrument components together in the same final packaging box, completely sealing each part in a sterile environment.

[0022] Please refer to Figures 1-4 The accommodating cavity is composed of an integrally formed rigid blister inner tray 10, which is fixed inside the box body 1. The rigid blister inner tray 10 is provided with a nesting groove 11 that is adapted to the shape of the syringe 2, filter needle 3, injection needle 4 and vial 5.

[0023] The nesting slots 11 have a two-row structure. One row contains the nesting slots 11 for holding the syringe 2, and the other row contains the nesting slots 11 for holding the filter needle 3, injection needle 4, and vial 5. The nesting slots 11 for holding the filter needle 3 and injection needle 4 are connected; the nesting slots 11 for holding the vial 5 and injection needle 4 are also connected. The nesting slots 11 for holding the filter needle 3 and injection needle 4 are composed of needle slots 13 and needle body slots of different widths.

[0024] The rigid blister inner tray 10 is provided with a snap-fit ​​structure 12 for detachably securing the syringe 2, filter needle 3 and injection needle 4 in their corresponding nesting grooves 11. The snap-fit ​​structure 12 is formed by protruding inward from the side wall of the nesting groove 11.

[0025] In this embodiment of the invention, the syringe 2, filter needle 3, and injection needle 4 are precisely placed in the corresponding nesting slots 11 of the integrally molded rigid blister insert 10. The snap-fit ​​structure 12 effectively secures the instruments, preventing them from shifting or colliding during transportation, thus ensuring the integrity and sterility of the instruments.

[0026] One corner of the box body 1 has a recessed stepped surface 15, which will form an easy-tear corner after plastic sealing, making it convenient to start tearing the plastic film at this point.

[0027] In use, the medical device supplier precisely places the self-manufactured syringe 2, filter needle 3, and injection needle 4 into the corresponding nesting slots 11 of the one-piece molded rigid blister tray 10. The snap-fit ​​structure 12 effectively secures the instruments, preventing displacement or collision during transportation and ensuring the integrity and sterility of the instruments. The rigid blister tray 10, now containing the instruments, is then placed into the box body 1. Following this, the first sealing operation is performed. During this process, precise positioning is achieved using the sealing mark 8 and positioning holes 9 on the box body 1, ensuring that the sealing film covers and seals the sealing area 6 only once. This area corresponds to all instrument components within the box, completely enclosing the syringe 2, filter needle 3, and injection needle 4 in a sterile environment. At this point, a semi-finished "integrated medical device package" with a reserved space for a vial 5 is complete, and the medical device supplier can supply this semi-finished product as a whole to the pharmaceutical manufacturer.

[0028] After receiving the semi-finished product packaging box, the pharmaceutical manufacturer can directly insert the produced vials 5 into the corresponding nesting slots 11 pre-reserved on the rigid blister tray 10 through the open operating port maintained in the secondary sealing area 7, without disassembling the already sterile sealed portion. After the medication is inserted, the pharmaceutical manufacturer uses the sealing equipment again, using the positioning hole 9 and sealing mark 8 for positioning, to perform heat sealing on the secondary sealing area 7. This sealing completely seals the pharmaceutical vials 5 together with the previously sealed medical device components in the same final packaging box.

[0029] Although embodiments of the present invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit, the scope of which is defined by the appended claims and their equivalents.

Claims

1. A secondary-sealing packaging box, characterized in that, include: The box body (1) has a cavity for accommodating the syringe (2), filter needle (3), injection needle (4) and vial (5); The box body (1) has a primary sealing area (6) and a secondary sealing area (7) at its opening. The primary sealing area (6) corresponds to the area in the accommodating cavity used to accommodate the syringe (2), filter needle (3), and injection needle (4). The secondary sealing area (7) corresponds to the area in the accommodating cavity used to accommodate the vial (5). The primary sealing area (6) and the secondary sealing area (7) are independent of each other, so that the sealing film can first cover and seal the primary sealing area (6), while the secondary sealing area (7) remains open and is resealed by the sealing film after being filled into the vial (5).

2. The secondary packaging box according to claim 1, characterized in that: The top of the box body (1) is provided with a sealing mark (8) for aligning the boundaries of the primary sealing area (6) and the secondary sealing area (7) when positioning the sealing film. The box body (1) is also provided with a positioning hole (9) that runs through its top and bottom for sealing and positioning.

3. The secondary packaging box according to claim 1, characterized in that: The accommodating cavity is composed of an integrally formed rigid blister inner tray (10), which is fixed inside the box body (1). The rigid blister inner tray (10) is provided with a nesting groove (11) that is adapted to the shape of the syringe (2), filter needle (3), injection needle (4) and vial (5).

4. A secondary packaging box according to claim 3, characterized in that: The nesting slots (11) are a two-row structure, with one row for holding the syringe (2) and the other row for holding the filter needle (3), injection needle (4) and vial (5).

5. A secondary packaging box according to claim 4, characterized in that: The nesting groove (11) for holding filter needles (3) and injection needles (4) is connected; the nesting groove (11) for holding vials (5) and injection needles (4) is connected.

6. A secondary packaging box according to claim 3, characterized in that: The nesting groove (11) used to hold the filter needle (3) and the injection needle (4) consists of needle grooves (13) and needle body grooves (14) of different widths.

7. A secondary packaging box according to claim 3, characterized in that: The rigid blister insert (10) is provided with a snap-fit ​​structure (12) for removably securing the syringe (2), filter needle (3) and injection needle (4) in their corresponding nesting slots (11).

8. A secondary packaging box according to claim 7, characterized in that: The snap-fit ​​structure (12) is formed by the inward protrusion of the side wall of the nested groove (11).

9. A secondary packaging box according to claim 1, characterized in that: The box body (1) has a downwardly recessed stepped surface (15) at one corner.